The DOI matches its Crossref record; 74 of the 77 references it cites were found in a registry or an index.
Hypoglycaemia in Type 2 diabetes
Open accessAbstract
The primary cause of hypoglycaemia in Type 2 diabetes is diabetes medication—in particular, those which raise insulin levels independently of blood glucose, such as sulphonylureas (SUs) and exogenous insulin. The risk of hypoglycaemia is increased in older patients, those with longer diabetes duration, lesser insulin reserve and perhaps in the drive for strict glycaemic control. Differing definitions, data collection methods, drug type/regimen and patient populations make comparing rates of hypoglycaemia difficult. It is clear that patients taking insulin have the highest rates of self‐reported severe hypoglycaemia (25% in patients who have been taking insulin for > 5 years). SUs are associated with significantly lower rates of severe hypoglycaemia. However, large numbers of patients take SUs in the UK, and it is estimated that each year > 5000 patients will experience a severe event caused by their SU therapy which will require emergency intervention. Hypoglycaemia has substantial clinical impact, in terms of mortality, morbidity and quality of life. The cost implications of severe episodes—both direct hospital costs and indirect costs—are considerable: it is estimated that each hospital admission for severe hypoglycaemia costs around £1000. Hypoglycaemia and fear of hypoglycaemia limit the ability of current diabetes medications to achieve and maintain optimal levels of glycaemic control. Newer therapies, which focus on the incretin axis, may carry a lower risk of hypoglycaemia. Their use, and more prudent use of older therapies with low risk of hypoglycaemia, may help patients achieve improved glucose control for longer, and reduce the risk of diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The effect of duration of diabetes on the proportion of patients experiencing severe hypoglycaemic episodes. The open circles represent patients in the intensive arm in the United Kingdom Prospective Diabetes Study (UKPDS) and show an increase in the proportion of patients experiencing a severe hypoglycaemic event over time. In contrast the closed circles represent patients in the diet-only arm of UKPDS and do not show an increase [21]. Reprinted from The Lancet, 352: UKPDS 33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes, 837–853, Copyright 1998, with permission from Elsevier.](/paper-figures/5adfd753fd3c48a49c2f7cc1937c5bb1/hypoglycaemia-in-type-2-diabetes-figure-1.jpg)
![FIGURE 2 Proportion of patients with Type 2 and Type 1 diabetes of differing durations and receiving different regimens experiencing at least one severe hypoglycaemic attack during 9–12 months’ follow-up. All patients were receiving insulin except the group treated with sulphonylurea [35]. Reproduced from [35] with kind permission of Springer Science and Business Media.](/paper-figures/e7b9acd663cc4480b7a0ff16afdffc1f/hypoglycaemia-in-type-2-diabetes-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“plasma glucose concentrations ≤3.9 mmol/l (70 mg/dl) sometimes occur in non-diabetic individuals [1,3].This is true, particularly in women and children, albeit generally during prolonged fasting.”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
In the citing paper
“they recommend a therapeutic plasma glucose concentration lower limit of 4.0-4.5 mmol/l (72-81 mg/dl).”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
In the citing paper
“Amiel et al. [3] also suggest a value of 3.5 mmol/l (63 mg/dl).”
From Preventing hypoglycaemia: what is the appropriate glucose alert value? (2009) · cites this paper as [3]
In the citing paper
“However, maintaining glycaemic control in patients is no easy task, as hypo- or hyperglycaemia can result from administration of the currently available treatments resulting in either too much or not enough, respectively, of an anti-hyperglycaemic effect.3,48”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Research works printed but not linked: 3
- Canadian Diabetes Association, 2003, Hypoglycemia, Can J Diabetes, 27, S43
- 10.1210/jc.82.5.1458 · DOI
- Curtis L, 2006, Unit Costs of Health and Social Care
Cited by
Sorted by citations
Items 101–200 of 472
Valentine, V., Newswanger, B., Prestrelski, S. J., Andre, A. D., & Garibaldi, M. L. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0148 · Cited by 49
Hypoglycemia Fear and Self-efficacy of Turkish Patients Receiving Insulin Therapy
Erol, Ö., & Enç, N. (2011) · Asian Nursing Research · doi:10.1016/j.anr.2011.12.001 · Cited by 49
Abdelghffar, E. A. R., Mostafa, N. M., El‐Nashar, H. A. S., Eldahshan, O. A., & Singab, A. N. B. (2022) · Industrial Crops and Products · doi:10.1016/j.indcrop.2022.114953 · Cited by 48
Jadhav, S., Reddy, P., Narayanan, K., & Bhosale, P. N. (2017) · Scientia Pharmaceutica · doi:10.3390/scipharm85030025 · Cited by 47
Khunti, K., Davies, M. J., & Kalra, S. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12053 · Cited by 45
Feigh, M., Henriksen, K., Andreassen, K. V., Hansen, C., Henriksen, J. E., Beck‐Nielsen, H., Christiansen, C., & Karsdal, M. A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01425.x · Cited by 45
Incretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus
Bourdel‐Marchasson, I., Schweizer, A., & Dejager, S. (2011) · Hospital Practice · doi:10.3810/hp.2011.02.369 · Cited by 46
Alsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 45
Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?
Paolisso, G., Monami, M., Marfella, R., Rizzo, M. R., & Mannucci, E. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0008-x · Cited by 44
Chan, S.-P., Ji, L.-N., Nitiyanant, W., Baik, S. H., & Sheu, W. H. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.05.008 · Cited by 44
Block of Kv1.7 potassium currents increases glucose‐stimulated insulin secretion
Finol‐Urdaneta, R. K., Remedi, M. S., Raasch, W., Becker, S., Clark, R. B., Strüver, N., Pavlov, E. V., Nichols, C. G., French, R. J., & Terlau, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200218 · Cited by 44
Khunti, K. K., Fisher, H., Paul, S. K., Iqbal, M., Davies, M. J., & Siriwardena, A. N. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.01.001 · Cited by 44
Neurologic damage in hypoglycemia
Mohseni, S. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00036-9 · Cited by 46
Hypoglycemia: From the Laboratory to the Clinic
Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc09-0113 · Cited by 44
Self-citationRaskin, P. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2403 · Cited by 42
Rosenstock, J., Fonseca, V. A., Schinzel, S., Dain, M., Mullins, P. R., & Riddle, M. C. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.003 · Cited by 44
Kenny, C. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.09.002 · Cited by 42
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years
Bolli, G. B., CHENG, A. Y. Y., & Owens, D. R. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01938-4 · Cited by 50
Owens, D. R., Traylor, L., Mullins, P. R., & Landgraf, W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.022 · Cited by 43
Resveratrol regulates hyperglycemia-induced modulations in experimental diabetic animal model
Rehman, K., Saeed, K., Munawar, S. M., & Akash, M. S. H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.050 · Cited by 41
(2014) · Europe PMC (PubMed Central) · Cited by 40
Management of type 2 diabetes mellitus in the elderly
Soe, K. K., Sacerdote, A. S., Karam, J., & Bahtiyar, G. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.07.006 · Cited by 40
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
Yun, J., & Ko, S. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.1.6 · Cited by 41
Torimoto, K., Okada, Y., Hajime, M., Tanaka, K., & Tanaka, Y. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0017 · Cited by 41
Giorda, C. B., Rossi, M. C., Ozzello, O., Gentile, S., Aglialoro, A., Chiambretti, A., Baccetti, F., Gentile, F. M., Romeo, F., Lucisano, G., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.10.005 · Cited by 41
Tan, C. C. L., Cheng, K. K. F., Hwang, S. W., Zhang, N., Holroyd, E. A., & Wang, W. (2018) · Clinical Nursing Research · doi:10.1177/1054773818792480 · Cited by 39
Self-monitoring of blood glucose in diabetes: is it worth it?
O’Kane, M., & Pickup, J. C. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009011 · Cited by 42
Hamming, K. S. C., Soliman, D., Webster, N. J., Searle, G. J., Matemisz, L. C., Liknes, D. A., Dai, X.-Q., Pulinilkunnil, T., Riedel, M. J., Dyck, J. R. B., et al. (2010) · Diabetes · doi:10.2337/db09-0630 · Cited by 38
Chow, L. S., Zmora, R., Ma, S., Seaquist, E. R., & Schreiner, P. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000527 · Cited by 37
Economic burden of hypoglycemia in patients with type 2 diabetes
Liu, S., Zhao, Y., Hempe, J. M., Fonseca, V., & Shi, L. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.87 · Cited by 37
Nicolucci, A., & Rossi, M. C. (2008) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 37
Hajos, T. R. S., Pouwer, F., de Grooth, R., Holleman, F., Twisk, J. W. R., Diamant, M., & Snoek, F. J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03329.x · Cited by 37
Albiglutide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Blair, H. A., & Keating, G. M. (2015) · Drugs · doi:10.1007/s40265-015-0370-5 · Cited by 37
Dejager, S., & Schweizer, A. (2011) · Diabetes Therapy · doi:10.1007/s13300-010-0018-0 · Cited by 37
Samya, V., Shriraam, V., Jasmine, A., Venguidesvarane, A. G., Rani, M. A., Durai, V., Gayathri, T., & Mahadevan, S. (2019) · Journal of Primary Care & Community Health · doi:10.1177/2150132719880638 · Cited by 45
Schwartz, S. S., & Kohl, B. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0468 · Cited by 36
Kostev, K., Dippel, F.-W., & Rathmann, W. (2014) · Primary Care Diabetes · doi:10.1016/j.pcd.2013.10.001 · Cited by 35
The Effects of Type 2 Diabetes on Cognitive Performance: A Review of Reviews
Sola, T., Sola, F.-M., & Jehkonen, M. (2024) · International Journal of Behavioral Medicine · doi:10.1007/s12529-024-10274-6 · Cited by 37
A Sustained Activation of Pancreatic NMDARs Is a Novel Factor of β-Cell Apoptosis and Dysfunction
Huang, X., Yue, S., Li, C., Huang, Y., Cheng, Q., Li, X., Hao, C., Wang, L., Xu, J.-P., Ji, M., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00366 · Cited by 36
Mbanya, J. C., Alsifri, S. N., Abdel-Rahim, A., & Satman, İ. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.04.030 · Cited by 34
Role of vildagliptin in managing type 2 diabetes mellitus in the elderly
Halimi, S., Raccah, D., Schweizer, A., & Dejager, S. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.485881 · Cited by 34
McIntosh, B., Cameron, C. G., Singh, S. R., Yu, C., Dolovich, L., & Houlden, R. L. (2012) · Europe PMC (PubMed Central) · Cited by 33
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
Gu, S., Mu, Y., Zhai, S., Zeng, Y., Zhen, X., & Dong, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165629 · Cited by 35
mPGES-2 blockade antagonizes β-cell senescence to ameliorate diabetes by acting on NR4A1
Zhong, D., Wan, Z., Cai, J., Quan, L., Zhang, R., Teng, T., Gao, H., Fan, C., Wang, M., Guo, D. M., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00536-6 · Cited by 35
Self-reported experience of hypoglycemia among adults with type 2 diabetes mellitus (Exhype)
Pettersson, B., Rosenqvist, U., Deleskog, A., Journath, G., & Wändell, P. E. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.005 · Cited by 33
Dziemidok, P., Makara‐Studzińska, M., & Jarosz, M. J. (2011) · PubMed · Cited by 32
Bonakdaran, S., & Khajeh-Dalouie, M. (2011) · PubMed · Cited by 32
Hypoglycaemia and gastric emptying
Marathe, C. S., Marathe, J. A., Rayner, C. K., Kar, P., Jones, K. L., & Horowitz, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13570 · Cited by 32
Ensling, M., Steinmann, W. C., & Whaley‐Connell, A. T. (2011) · Cardiorenal Medicine · doi:10.1159/000322886 · Cited by 31
Complementing Insulin Therapy to Achieve Glycemic Control
Barnett, A. H. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0039-y · Cited by 33
Boland, C. L., DeGeeter, M., Nuzum, D. S., & Tzefos, M. (2013) · Annals of Pharmacotherapy · doi:10.1345/aph.1r444 · Cited by 32
Hartley, P., Shentu, Y., Betz-Schiff, P., Golm, G. T., Sisk, C. M., Engel, S. S., & Shankar, R. R. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0271-z · Cited by 31
Diabetes Management in the Kidney Patient
Garg, R., & Williams, M. E. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.11.001 · Cited by 32
Glycaemic goals in patients with type 2 diabetes: current status, challenges and recent advances
Khunti, K., & Davies, M. J. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01186.x · Cited by 31
Barnett, A. H. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003738063 · Cited by 34
NMDAR antagonists for the treatment of diabetes mellitus—Current status and future directions
Welters, A., Kluppel, C. A., Mrugala, J., Wörmeyer, L., Meißner, T., Mayatepek, E., Heiß, C., Eberhard, D., & Lammert, E. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13017 · Cited by 34
Grammes, J., Schäfer, M., Benecke, A., Löw, U., Klostermann, A.-L., Kubiak, T., & Witthöft, M. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.12.010 · Cited by 31
Budiman, E. S., Samant, N. D., & Resch, A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700213 · Cited by 30
Prescribing errors in diabetes
Cox, A. R., & Ferner, R. E. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409103902 · Cited by 30
Gallwitz, B. (2013) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018813486165 · Cited by 20
On what evidence-base do we recommend self-monitoring of blood glucose?
Kolb, H., Kempf, K., Martin, S., Stümvoll, M., & Landgraf, R. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.014 · Cited by 29
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy
Monnier, L., Colette, C., Dejager, S., & Owens, D. R. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9325-8 · Cited by 29
Reza, M. S., Shuvo, M. S. R., Hassan, M. M., Basher, M. A., Islam, M. A., Naznin, N. E., Jafrin, S., Ahmed, K. S., Hossain, H., & Daula, A. F. M. S. U. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110942 · Cited by 29
Gallwitz, B., & Häring, H. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01095.x · Cited by 29
Farmer, A. A., Balman, E., Gadsby, R., Moffatt, J., Cradock, S., McEwen, L. M., & Jameson, K. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802473062 · Cited by 28
Self-citationAntidiabetic activity and chemical constituents of the aerial parts of Heracleum dissectum Ledeb.
Zhang, H., Su, Y., Wang, X., Mi, J., Huo, Y., Wang, Z., Liu, Y., & Gao, Y. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2016.07.065 · Cited by 29
Li, X., Yu, S., Zhang, Z., Radican, L., Cummins, J., Engel, S. S., Iglay, K., Duke, J. D., Baker, J., Brodovicz, K. G., et al. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1636016 · Cited by 29
Mitsuishi, S., Nishimura, R., Harashima, S., Kawamura, T., Tsujino, D., Koide, K., Nishimura, A., Utsunomiya, K., Inagaki, N., & Atsumi, Y. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0649-x · Cited by 28
Verma, N., Amresh, G., Sahu, P. K., Rao, C. V., & Singh, A. P. (2012) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(12)60212-3 · Cited by 27
Simon, D., de Pablos-Velasco, P. L., Parhofer, K. G., Gonder-Frederick, L. A., Duprat-Lomon, I., Vandenberghe, H., Eschwège, É., & Bradley, C. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.08.007 · Cited by 28
Unexplained Hypoglycaemia and Large Glycaemic Variability: Skin Lipohypertrophy as a Predictive Sign
Strollo, F., Guarino, G., Armentano, V., Clemente, G., Martedì, E., Riu, S. D., Gaeta, I., Corigliano, G., Ceriello, A., & Gentile, S. (2016) · Diabetes Research - Open Journal · doi:10.17140/droj-2-126 · Cited by 28
Nanjala, C., Odago, W. O., Rono, P. C., Waswa, E. N., Mutinda, E. S., Oulo, M. A., Muema, F. W., Wanga, V. O., Mkala, E. M., Kuja, J., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115404 · Cited by 27
Hassanein, M., Zainudin, S. B., Shaikh, S. S., Shaltout, I., Malek, R., Büyükbeşe, M. A., Alfadhli, E. M., Shaikh, K. A., Hussein, Z. B., Eliana, F., et al. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2385057 · Cited by 26
Malha, L. P., Taan, G., Zantout, M. S., & Azar, S. T. (2014) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018814529062 · Cited by 26
Kadowaki, T., Kondo, K., Sasaki, N., Miyayama, K., Yokota, S., Terata, R., & Gouda, M. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1359259 · Cited by 25
Integrating oral semaglutide into clinical practice in primary care: for whom, when, and how?
Brunton, S., Mosenzon, O., & Wright, E. E. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1798162 · Cited by 25
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
Yen, F., Hou, M., Liu, J., Hsu, C., & Hwu, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.962337 · Cited by 27
Belsey, J., Pittard, J., Rao, S. R., Urdahl, H., Jameson, K., & Dixon, T. M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01992.x · Cited by 25
Self-citationÅhrén, B. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0179-x · Cited by 25
Tan, P., Chen, H., Taylor, B. J., & Hegney, D. G. (2012) · International Journal of Evidence-Based Healthcare · doi:10.1111/j.1744-1609.2012.00276.x · Cited by 25
Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003–2012
Zaharan, N. L., Williams, D. J., & Bennett, K. (2013) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-013-1011-1 · Cited by 24
Jensen, M. V., Broadley, M. M., Speight, J., Scope, A., Preston, L., Heller, S. R., de Galan, B. E., Pouwer, F., & Hendrieckx, C. (2021) · Diabetic Medicine · doi:10.1111/dme.14666 · Cited by 23
Inagaki, N., Goda, M., Yokota, S., Maruyama, N., & Iijima, H. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1055250 · Cited by 23
Feigh, M., Andreassen, K. V., Neutzsky-Wulff, A. V., Petersen, S., Hansen, C., Bay‐Jensen, A., Henriksen, J. E., Beck‐Nielsen, H., Christiansen, C., Henriksen, K., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01979.x · Cited by 23
Aziz, K. M. A. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s54683 · Cited by 23
Pandya, N., DIGENIO, A. G., Gao, L., & Patel, M. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0069-9 · Cited by 23
Hypoglycemia and cognitive function in diabetic patients
Ebadi, S. A., Darvish, P., Fard, A. J., Lima, B. S., & Ahangar, O. G. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.05.011 · Cited by 22
Núñez, M., Díaz‐Cerezo, S., Dilla, T., Reviriego, J., & Pérez, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0563-0 · Cited by 23
Gallwitz, B., Rosenstock, J., Emser, A., von Eynatten, M., & Woerle, H. J. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12101 · Cited by 22
Validation of the new IDF-DAR risk assessment tool for Ramadan fasting in patients with diabetes
Mohammed, N., Buckley, A. J., Siddiqui, M., Ahmed, S. A., Afandi, B. O., Hassanein, M. M., Lessan, N. G., & Suliman, M. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102754 · Cited by 22
Asche, C. V., Luo, W., & Aagren, M. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.825590 · Cited by 22
Severe hypoglycaemia in drug-treated diabetic patients needs attention: A population-based study
Honkasalo, M., Elonheimo, O., & Sane, T. (2011) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2011.580090 · Cited by 22
Update on strategies limiting iatrogenic hypoglycemia
Bonaventura, A., Montecucco, F., & Dallegri, F. (2015) · Endocrine Connections · doi:10.1530/ec-15-0044 · Cited by 22
Altunok, İ., Aksel, G., & Eroğlu, S. E. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.08.045 · Cited by 22
Pharmacokinetics and pharmacodynamics of glimepiride polymorphs
Viana, A. L. M., Doriguetto, A. C., Viana, O. M. M. S., Ruela, A. L. M., Freitas, J. T. J., Souto, B. E. M., Araújo, M. B., & Paula, F. B. D. A. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.10.050 · Cited by 22
Antidiabetic and hepatoprotective activity of the roots of Calanthe fimbriata Franch
Peng, Y., Gao, Y., Zhang, X., Zhang, C., Wang, X., Zhang, H., Wang, Z., Liu, Y., & Zhang, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.066 · Cited by 22
Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD
Chow, L. S., Chen, H., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetologia · doi:10.1007/s00125-015-3512-0 · Cited by 22
Gallop, M. R., Vieira, R. F. L., Matsuzaki, E. T., Mower, P. D., Liou, W., Smart, F. E., Roberts, S., Evason, K. J., Holland, W. L., & Chaix, A. (2025) · Science Advances · doi:10.1126/sciadv.adx2752 · Cited by 21
Hanif, W., Malik, W., Hassanein, M., Kamal, A., Geransar, P., Andrews, C., Azam, M., & Barnett, A. H. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.803054 · Cited by 21
Rajendran, R., Hodgkinson, D. W., & Rayman, G. A. (2015) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2014-132926 · Cited by 21
Metadata
- Authors
- Amiel, S. A., Dixon, T., Mann, R., & Jameson, K.
- Affiliations
- King's College London (GB)
- University of Sheffield (GB)
- MSD (UK) Limited (United Kingdom) (GB)
- Corresponding author
- Amiel, S. A.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2008-02-27
- Volume
- 25
- Issue
- 3
- Pages
- 245-254
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- PMC
- PMC2327221
- OpenAlex
- W2156888511
- Cited by
- 472
- References
- 77
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 10 · 2023: 11 · 2022: 15 · 2021: 14 · 2020: 15 · 2019: 22 · 2018: 34 · 2017: 17 · 2016: 29 · 2015: 33 · 2014: 46 · 2013: 55 · 2012: 46
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, type 2 diabetes, sulfonylureas, insulin therapy, severe hypoglycemia, glycemic control, incretin-based therapy, hospital costs, diabetes complications
- MeSH terms
- Diabetes Mellitus, Type 2, Hospitalization, Humans, Hypoglycemia, Insulin, Risk Factors, Sulfonylurea Compounds, Antidiuretic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
